BMS-866949

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

DepressionMajor Depression

Phase 1

Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects

CompletedNCT00949767

Bristol-Myers SquibbDepression

Start: 2009-07-31End: 2010-03-31Updated: 2011-01-25

Safety and Pharmacology Study of BMS-866949

TerminatedNCT01124344

Bristol-Myers SquibbMajor Depression

Start: 2010-05-31End: 2011-11-30Updated: 2012-03-27